Inovalon Acquires VigiLanz; a Leading Clinical Surveillance and Patient Safety SaaS and Data Company
Acquiring Company
Inovalon
Acquired Company
VigiLanz
Description
Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, has announced the acquisition of VigiLanz, a rapidly growing SaaS-based clinical surveillance and patient safety software and data company. This acquisition enriches Inovalon’s provider and life sciences solution portfolios, expands its customer base, and increases the Company’s clinical data connectivity, further accelerating its growth in data-enabled healthcare solutions.
Quick answer
Inovalon is acquiring VigiLanz, announced February 5, 2024. Inovalon is based in Bowie, Maryland, United States.
- How much did Inovalon pay for VigiLanz?
- The deal value was not disclosed.
- What does Inovalon do?
- Inovalon is a leading provider of cloud-based software solutions empowering data-driven healthcare.
- Where are Inovalon and VigiLanz based?
- Inovalon is based in Bowie, Maryland, United States. VigiLanz is based in Minneapolis, Minnesota, United States.
- Who are the decision-makers at Inovalon?
- Fundz holds 3 contacts at Inovalon. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Software Development and Hospitals and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Bristol Myers Squibb completes acquisition of Karuna Therapeutics, Inc. to strengthen its neuroscience portfolio (March 18, 2024)
- Novartis completes acquisition of IFM Due to develop first-in-class STING antagonist program targeting innate immune system (March 13, 2024)
- Branded Legacy, Inc. signs letter of intent to purchase Sycamore BioPharma, LLC, to strengthen its position in the BioTech industry (March 1, 2024)
- XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right (February 16, 2024)
- Novo Holdings to Acquire Catalent (February 5, 2024)
- Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics (January 18, 2024)
Who to call at Inovalon, and when
When Inovalon changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Inovalon raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inovalon, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inovalon. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inovalon makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired VigiLanz?
VigiLanz was acquired by Inovalon, based in Bowie. The deal was reported on February 5, 2024. Inovalon is a leading provider of cloud-based software solutions empowering data-driven healthcare. Inovalon is privately held and operates in Software Development.
When did Inovalon acquire VigiLanz?
Inovalon's acquisition of VigiLanz was reported on February 5, 2024. Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, has announced the acquisition of VigiLanz, a rapidly growing SaaS-based clinical surveillance and patient safety software and data company. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does VigiLanz do?
When your hospital’s clinical and business data work together, healthier outcomes are possible. VigiLanz is the clinical surveillance platform that brings your data full circle—delivering meaningful insights that help you and your patients thrive. It is privately held, operating in Biotechnology, and is based in Minneapolis.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.